Snowball logo
logo
UR9

Clinuvel Pharmaceuticals Limited

UR9 MU
5.760.00  (0%)
Estimate
P/E
25.4
EPS
0.227
Beta
1.071
Dividends
Dividend yield
0.32%
Annual payout
AU$0.03
Next ex. div date
September 4, 26
Payout
6.92%
Div.growth, 5y
14.88%
Div.rating
About the company
Ticker
UR9
ISIN
Country
Australia
Sector (GICS)
Materials
There is no Profile data available for UR9.MU.

Frequently asked questions

What sector does Clinuvel Pharmaceuticals Limited (UR9) operate in?

Clinuvel Pharmaceuticals Limited belongs to the Materials sector and operates in the Other industry.

What is Clinuvel Pharmaceuticals Limited (UR9) current stock price?

As of the latest data, Clinuvel Pharmaceuticals Limited stock price is €5.76, with a previous close of €5.76.

What is Clinuvel Pharmaceuticals Limited (UR9) current market capitalization?

Clinuvel Pharmaceuticals Limited market cap is approximately 275.47 million.

What is Clinuvel Pharmaceuticals Limited (UR9) Earnings Per Share (EPS)?

The trailing EPS is €0.23.

What is Clinuvel Pharmaceuticals Limited (UR9) Price-to-Earnings (P/E) ratio?

Clinuvel Pharmaceuticals Limited current P/E ratio is 25.37.

Does Clinuvel Pharmaceuticals Limited (UR9) pay dividends?

Yes. Clinuvel Pharmaceuticals Limited pays annual dividends with an annualized yield of 0.32% and an estimated annual payout of €0.03 per share.

When is the next ex-dividend date for Clinuvel Pharmaceuticals Limited (UR9)?

The next ex-dividend date is scheduled for September 04, 2026.

When is Clinuvel Pharmaceuticals Limited (UR9) next earnings report?

Clinuvel Pharmaceuticals Limited is expected to release its next earnings report on June 30, 2026.

What is Clinuvel Pharmaceuticals Limited (UR9) beta (volatility) score?

Clinuvel Pharmaceuticals Limited has a beta of 1.071, meaning its volatility is roughly in line with the market.